TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
ARVN

Arvinas Inc

Healthcare · Biotechnology

7.80$ -0.5% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Cash Flow

All figures per share in USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow ARVN
Line item 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-1.09 0.25 -0.51 -1.23 -2.27 11.19 -5.14 -6.27 -3.61 -4.22
0.02 0.02 0.02 0.07 0.10 0.12 0.15 0.12 0.09 0.08
0.03 0.01 0.37 0.61 0.76 1.14 1.42 1.29 1.23 0.68
0.00 0.03 0.37 0.61 0.75 1.31 1.42 – – –
-0.31 1.36 0.40 0.22 -0.15 13.57 -1.55 -0.80 -1.96 -3.60
0.02 0.05 0.09 0.19 0.16 0.09 0.13 0.05 0.03 0.03
-1.12 1.01 -5.68 -2.83 4.15 -26.27 4.56 3.67 0.48 6.28
– – 1.91 0.10 – – – – – –
– – -0.11 -0.02 -0.74 0.28 0.09 0.00 0.00 -1.42
-0.01 -0.01 0.06 -0.01 – 0.00 0.00 0.00 -0.01 0.00
-0.01 -0.01 5.31 4.24 12.77 5.57 0.09 6.75 0.11 -1.41
-2.22 1.25 -0.88 0.18 14.65 -9.51 -0.49 4.15 -3.01 0.65
-1.10 0.20 -0.60 -1.42 -2.43 11.09 -5.27 -6.32 -3.63 -4.25

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?